FLOORZ
Main information
- Trade name:
- FLOORZ 10 TAB
- Active ingredient:
- Ofloxacin,Ornidazole
- Available from:
- N. V. LIFE
- Dosage:
- 200,500;MG
- Pharmaceutical form:
- TAB
- Composition:
- 10
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
12-6-2018
Human medicines European public assessment report (EPAR): Quinsair, levofloxacin, Revision: 7, Authorised
Europe - EMA - European Medicines Agency
4-5-2018
Opinion/decision on a Paediatric investigation plan (PIP): , Levofloxacin (hemihydrate), Therapeutic area: Pneumology-allergology
Europe - EFSA - European Food Safety Authority EFSA Journal
3-2-2014
Danish Pharmacovigilance Update 28 November 2013
In this issue of Danish Pharmacovigilance Update: Ciprofloxacin and the risk of tendon disorders, risk of blood clots from the use of the cancer medicine ponatinib and reporting of adverse reactions to the Danish Health and Medicines Authority.
Danish Medicines Agency
10-9-2018
Ciprofloxacin hydrochloride / hydrocortisone: List of nationally authorised medicinal products - PSUSA/00000774/201711
Europe - EMA - European Medicines Agency
13-6-2018
Veraflox (Bayer Animal Health GmbH)
Veraflox (Active substance: Pradofloxacin) - Centralised - Yearly update - Commission Decision (2018)3834 of Wed, 13 Jun 2018
Europe -DG Health and Food Safety
11-6-2018
Quinsair (Chiesi Farmaceutici S.p.A.)
Quinsair (Active substance: levofloxacin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3756 of Mon, 11 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2789/T/16
Europe -DG Health and Food Safety